Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Validation and interpretation of the Dutch version of the Multiple Sclerosis Neuropsychological Screening Questionnaire.
Peripheral neuropathy associated with mitochondrial disease in children.
A CB(1)/CB(2) receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin.
Pitfalls of 3D FLAIR Brain Imaging: A Prospective Comparison with 2D FLAIR.
[Possibilities of using the 2010 McDonald criteria for early diagnosis of multiple sclerosis.]
Tysabri screening test may be unreliable
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?
Effects of non-steroidal antiinflammatory drugs on D-serine-induced oxidative stress in vitro.
Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis.
Simvastatin inhibits interferon-gamma-induced MHC class II up-regulation in cultured astrocytes.
Physical fitness assessment in multiple sclerosis patients: A controlled study.
Autologous T Cell Vaccine (TCV) for Multiple Sclerosis (TERMS)
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.
Generation and characterization of spiking and non-spiking oligodendroglial progenitor cells from embryonic stem cells.
The Afferent Visual Pathway: Designing a Structural-Functional Paradigm of Multiple Sclerosis.
Four different synthetic peptides of proteolipid protein induce a distinct antibody response in MP4-induced experimental autoimmune encephalomyelitis.
Acute disseminated encephalomyelitis after tetanus vaccination of a pregnant woman in Senegal.
[Optic neuritis: diagnosis, treatment and clinical implications].
Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis - Association and Prediction.
Multiple sclerosis reactivation postfingolimod cessation: Is it IRIS?
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.
Review: the role of vitamin D in nervous system health and disease.
Inhibition of Calcineurin Abrogates While Inhibition of mTOR Promotes Regulatory T Cell Expansion and Graft-Versus-Host Disease Protection by IL-2 in Allogeneic Bone Marrow Transplantation.
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study.
Pages
« first
‹ previous
…
221
222
223
224
225
226
227
228
229
…
next ›
last »